Key points
==========

-   The master circadian clock in the brain\'s suprachiasmatic nuclei provides daily timing cues for other circadian oscillators in the brain and body, and is itself synchronised to the external world through recurring changes in environmental light levels.

-   Here we show that in addition to lengthening circadian period, the after-hours (*Afh*) mutation alters daily rhythms in metabolism, and reduces the amplitude of oscillations in circadian timekeepers in the brain and periphery. Such suppression in circadian oscillation could be visualised in single brain cells. Intriguingly, the *Afh* mutation greatly enhanced resetting of the circadian system to stimuli such as environmental light.

-   Collectively the results indicate unusual consequences of the *Afh* mutation, from single cells to whole animal physiology and behaviour.

Introduction
============

Circadian clocks are biological pacemakers that drive daily rhythms in physiology and behaviour, such as sleep, metabolism, core body temperature and hormone secretion ([@b31]). In mammals, the master circadian clock is housed within the suprachiasmatic nuclei (SCN) of the hypothalamus. However, semi-autonomous circadian clocks have been demonstrated in multiple cell types and tissues outside of the SCN ([@b6]; [@b42]; [@b1]; [@b17]). Using brain tissues from PER2 reporter mice (PERIOD2::LUCIFERASE (PER2::LUC); [@b43]), we have demonstrated that circadian rhythms are detectable in a number of extra-SCN brain sites. Notably, these include hypothalamic structures involved in feeding behaviour and metabolic control, such as the dorsomedial hypothalamus (DMH), arcuate nucleus (Arc) and median eminence (ME), as well as the pars tuberalis (PT) of the pituitary gland (PIT) and the habenula (Hb) of the epithalamus ([@b15], [@b16]). Therefore, it is now clear that a network of clocks located across the brain and body orchestrates circadian rhythms in behaviour and physiology.

The molecular clockwork that underlies circadian rhythmicity involves interlocking transcriptional and translational feedback loops centred upon the reciprocal interaction of transcriptional activators CLOCK and Brain and Muscle ARNT-Like 1 (BMAL1), and repressors PERIOD (PER) and CRYPTOCHROME (CRY; [@b25]). This central feedback loop is acted upon by a number of secondary and tertiary loops that stabilise its oscillation. Critically, fine-tuning of clock speed arises from phosphorylation and ubiquitination of clock proteins so that each cycle typically takes ∼24 h, and mutations that influence post-translational modification of these proteins alter clock speed in both humans and animals ([@b30]; [@b26]).

Behavioural screening of mutagenised mice recently identified two mouse lines in which circadian periods were significantly lengthened compared with control +/+ mice; subsequently named 'after-hours' (*Afh*; [@b13]) and 'overtime' ([@b36]) mutants. Both mutations were mapped to the *Fbxl3* gene, a member of the F-box family that regulates protein ubiquitination and degradation and, although different, both mutations were found to disrupt the interaction of FBXL3 with CRY ([@b8]; [@b36]). The ensuing reduction in the degradation of CRY prolongs the repressive effects of CRY on the molecular clock, thereby lengthening the period of each cycle. Initial characterisation of the *Afh* mice revealed a profound lengthening of circadian period in behavioural wheel-running activity, as well as PER2::LUC rhythms in SCN, kidney, lung and liver tissue slices *in vitro*. In addition to an increased period length, the amplitude of PER2 rhythms is significantly reduced in tissue derived from these animals ([@b13]).

In the current study, we further characterise the physiological impact of the *Afh* mutation. We demonstrate that rhythms in metabolic rate and feeding behaviour are both dampened and phase-delayed in mutant mice compared with control +/+ littermates. Consistent with altered metabolic rhythms, the *Afh* mutation lowers the amplitude of single-cell oscillations in the SCN as well as structures of the mediobasal hypothalamus (MBH) and the PIT. Importantly, we also show that the *Afh* mutation results in high-amplitude phase-resetting of the circadian system, evident in both isolated tissue cultures in vitro as well as wheel-running *in vivo* responses to nocturnal light pulses. Collectively, this study establishes that the *Afh* mutation has widespread effects on the circadian system, and has important implications for patients with disrupted circadian rhythmicity, such as that observed in delayed sleep phase syndrome.

Methods
=======

Ethical approval
----------------

All experiments were performed in accordance with the UK Animals (Scientific Procedures) Act of 1986 using procedures approved by The University of Manchester Review Ethics Panel.

Animals
-------

The University of Manchester colony of *Afh* mice was derived from three breeding pairs of homozygous male (*Fblx3^Afh/Afh^*; referred to in this study as *Afh*/*Afh* mice) × heterozygous female (*Fblx3^Afh/+^*; referred to in this study as *Afh*/+ mice) animals provided by Dr Michael Hastings, MRC Laboratory of Molecular Biology, Cambridge, UK. This strain was originally generated by Prof. Pat Nolan at the Mammalian Genetics Unit, MRC Harwell, Oxfordshire, UK (see [@b13] for full description). All original breeding stock had been backcrossed for 9--10 generations on the *mPer2Luc* homozygous mouse ([@b43]). Prior to study, mice were group housed and maintained with *ad libitum* access to food and water under a 12 h light/12 h dark (LD) cycle (where Zeitgeber time (ZT) 0 designates lights-on and ZT12 indicates lights-off). In constant lighting conditions circadian time (CT) 12 is defined as the onset of behavioural activity. Ambient temperature was maintained at 20--22°C and humidity at ∼40%. The light intensity in the breeding colony was ∼44 μW cm^−2^. Mice were genotyped using an allelic discrimination assay as previously described ([@b13]). Experiments were conducted on age- and sex-matched adult mice, using congenic *Fblx3^+/+^* littermates, referred to in this study as +/+ controls.

Behavioural analysis
--------------------

### Wheel-running behaviour

To assess wheel-running behaviour in LD and constant darkness (DD), male and female control (+/+; *n*= 14), heterozygous (*Afh*/+; *n*= 8) and homozygous mutant (*Afh*/*Afh*; *n*= 12) mice were individually housed in cages equipped with a stainless-steel running wheel (160 mm diameter) under a 12 h:12 h LD cycle for a minimum of 14 days then released into DD for at least 14 days. The intensity of light during lights-on was ∼56 μW cm^−2^. Wheel-running data were monitored throughout the experiment and recorded in 10 min time bins using the Chronobiology Kit (Stanford Software Systems, Santa Cruz, CA, USA).

### Drinking rhythms

Water intake was measured using the Labmaster system (TSE systems, Bad Homburg, Germany). The Labmaster system consists of a chamber (425 × 265 × 150 mm) that incorporates sensitive sensors for online measurement of water consumption. Mice (+/+, *n*= 5; *Afh*/+, *n*= 5, *Afh*/*Afh*, *n*= 6) were acclimatised to the cages for at least 4 days prior to recordings, following which drinking rhythms were monitored for at least 14 days in LD and a further 14 days in DD. Standard chow and tap water were supplied *ad libitum* throughout the experiments. Water intake over time was recorded continuously and exported into Microsoft Excel in 30 min time bins.

Metabolic experiments
---------------------

### Indirect calorimetry

The metabolic rate of +/+ (*n*= 9) and *Afh*/*Afh* (*n*= 11) mice was assessed via indirect calorimetry, using a Comprehensive Lab Animal Monitoring System (CLAMS; Columbus Instruments, Columbus, OH, USA). Animals were individually housed in calorimetric cages and oxygen consumption (VO~2~) measured every 10 min for 7 days, under a 12 h:12 h LD photoperiod. Standard rodent chow and water were available *ad libitum* throughout experiments. Activity at the food hopper was assessed using an infrared laser beam across the opening of the hopper. The number of beam breaks (≥1 s duration) was recorded in 10 min time bins.

Phase--response curve to light
------------------------------

To determine whether phase shifting to an external stimulus was altered by the *Afh* mutation, we examined the phase-resetting effect of light pulses given to +/+ (*n*= 8) and *Afh*/*Afh* (*n*= 8) mice free-running in DD. Initially, mice were individually housed in running wheel (80 mm diameter)-equipped cages under a 12 h:12 h LD cycle for 1 week then released into DD to free-run for 10 days prior to the start of the phase-shift experiment. Mice were presented with a series (*n*= 3) of light pulses (∼60 μW cm^−2^) approximately every 2 weeks at a range of times across the circadian cycle. CT was calculated from the free-running period of each individual mouse. Because the free-running period and hence the time of one circadian day differed between +/+ and *Afh*/*Afh* mice (average period in first epoch of DD: +/+ 23.6 ± 0.07 h; *Afh*/*Afh* 25.7 ± 0.12 h), the times and lengths of the light pulses were adjusted accordingly to cover the same proportion of the circadian cycle. Consequently all light pulses given to +/+ animals were 6 h in length, and all light pulses given to *Afh*/*Afh* mice were 6.5 h. This length of stimuli was chosen in accordance with similar studies in mice on a C57/BL6 background ([@b39]) to produce consistent, effective phase shifts. Care was taken not to pulse mice in the same portion of the circadian cycle more than once. Light pulses were delivered through timed programming of an LED Light-Controlled Ventilated Cabinet (Tecniplast, Buguggiate, Italy).

PER2::LUC bioluminescence experiments
-------------------------------------

### Culture preparation

Mice were culled by cervical dislocation following isoflurane anaesthesia (Abbott Laboratories, Kent, UK). All cultures were prepared from animals that had been behaviourally screened and were free-running in DD. Animal handling and brain extraction were conducted with the aid of night vision goggles to prevent exposure of animals to visible light. For luminometric assessment on photomultiplier tube (PMT) assemblies (see below), SCN, arcuate complex (Arc complex: Arc, ME, PT), DMH and Hb were microdissected and cultured as 250 μm coronal sections, as previously described (Guilding *et al.* 2009, 2010). Pituitaries were dissected by hand and cultured whole under identical conditions. For bioluminescence imaging experiments, coronal SCN and/or MBH explants containing DMH, ventromedial hypothalamus, Arc, ME and PT were dissected and cultured at 37°C as previously described ([@b15]).

### Luminometry

Total bioluminescence was recorded from individual brain slice cultures for up to 7 days with PMT assemblies (H8259/R7518P; Hamamatsu, Welwyn Garden City, UK) housed in a light-tight incubator (Galaxy R+; RS Biotech, Irvine, UK) maintained at 37°C. Photon counts were integrated for 299 s every 300 s. All bioluminescence data were detrended by subtracting a 24 h running average from the raw data and smoothed with a 3 h running average.

### Bioluminescence imaging

Bioluminescence emission from SCN or MBH cultures maintained at 37°C was imaged with a self-contained Olympus LV200 luminescence microscopy system fitted with a cooled Hamamatsu C9100-13 EM-CCD camera (Olympus, Japan), as previously described (Guilding *et al.* 2009, 2010). Individual regions of interest and single cells were delineated using ImageJ software (version 1.37a; NIH, USA).

Data analysis and statistics
----------------------------

### Wheel-running behaviour

Analysis of locomotor activity under LD conditions was carried out on the final 10 days of LD. Data recorded under DD conditions were analysed on successive 10 day epochs immediately following the LD cycle (DD~1-10~ and DD~10−20~). Period and rhythm strength of wheel-running rhythms were calculated using χ^2^ periodogram analysis in the Analyse9 software package (Stanford Software Systems). Rhythm strength was expressed as percentage of variance (%*V*) explained by the dominant component of the rhythm; %*V* is derived from the power of the χ^2^ periodogram peak (%*V*=*Q*~p~× 100/*n*, where *Q*~p~ is the power of the rhythm and *n* is the number of time bins included in the periodogram analysis). Rhythm strength in DD~10−20~ was also calculated relative to DD~1-10~ to determine whether this deteriorated more quickly under DD in *Afh*/*Afh* than in +/+ animals. Time of activity onset on the final day in LD and subsequent phase shift on transfer to DD were determined manually using eye-fit regression lines. Wheel revolution counts were exported into Microscoft Excel in 10 min time bins to calculate average locomotor activity (wheel revolutions h^−1^) and percentage total activity observed in the dark phase (under LD). The ZT of peak activity was estimated for each individual mouse using 24 h mean activity profiles, normalised such that the peak was equal to one and the nadir equal to zero. Wheel-running data were further outputted to El Temps analysis software (Dr A. Díez-Noguera, Barcelona, Spain) to determine the duration of the main active phase (alpha) and percentage of activity during alpha. Alpha was determined using an average waveform, and points where activity crossed the mean activity level were defined as onset and offset. All measurements were performed blind to genotype. Comparisons between genotypes were carried out using one-way ANOVA with Tukey\'s *post hoc* test (SYSTAT version 10, Chicago, IL, USA; *P* \< 0.05 required for statistical significance).

### Drinking rhythms

Total water intake (ml per day) and percentage drinking activity during the dark phase (in LD) were calculated in Microsoft Excel. Water consumption (30 min time bins) was outputted to El Temps, and actograms plotted of individual drinking rhythms. Period and %*V* were determined by χ^2^ periodogram analysis ([@b37]) for the final 10 days in LD and on the first 14 days in DD. Alpha duration and percentage activity during alpha were determined using average waveform analysis, as described for wheel-running data. Statistical differences between genotypes were assessed with one-way ANOVA and Tukey *post hoc* test (SYSTAT; *P* \< 0.05 required for statistical significance).

### Analysis of metabolic rhythms

Data for O~2~ consumption and food hopper visits were analysed in Matlab (Mathworks, MA, USA) using custom-written scripts ([@b7]). Diurnal rhythmicity was assessed by χ^2^ analysis ([@b37]), with significance set at *P* \< 0.001. Timing of peak activity and peak−trough amplitudes were computed from 24 h means of O~2~ consumption and food hopper visits for each individual (over 7 days under LD). Comparisons of these parameters between genotypes were by unpaired *t* test with significance set at *P* \< 0.05. Data are presented as mean ± SEM. For direct comparison of daily activity profiles between genotypes, 24 h means for each individual were first normalised to lie between 1 and 0. Data were averaged according to genotype and the resulting means renormalised.

### Phase shifts to light

Behavioural phase shifts were measured using eye-fit regression lines on 7 days of activity before and after a pulse, discounting transient cycles following a shift. Time of activity onset (CT12) on the day of the pulse was calculated from a line eye-fit through times of activity onset for the 7 days before the light pulse. Period estimates were calculated using the same 7 day period. The CT at the start of each light pulse was calculated from the CT12 and period. A second line of best fit was fitted through the activity onsets for the 7 days following the light pulse (actograms were plotted to depict circadian days depending on the stable free-running period of individual animals). The time difference between the two extrapolated lines on the day of the pulse was the magnitude of the phase shift. This value was corrected for each individual animal\'s circadian period, estimated before the light pulse. Phase shift direction and magnitude were assessed by three experienced researchers blind to genotype and time of pulse. The means of these rated shifts were subsequently plotted against the CT at the start of the pulse to give the phase--response curve. To highlight any differences between genotypes in phase-resetting, data were also plotted as a phase--transition curve ([@b22]; [@b23]). Here, the 'new phase' post-light pulse is plotted against the CT of the light pulse (old phase); hence, if a light pulse was applied at CT14 and this resulted in a 2 h phase-delay, the new phase would be CT12. The slope of this graph provides an indication of how sensitive a system is to perturbations. If the circadian system is resilient to the perturbation of a light pulse, there will be little difference between the old and new phase, and the slope of the graph will be 1, indicating a Type 1 phase-resetting. Conversely, if the circadian system is highly sensitive to being reset by light, the new phase will be related to the time of the light pulse rather than the old phase, and the slope of the graph will be 0 ([@b40]).

### Bioluminescence

Molecular rhythms were analysed using curve-fitting software (Clockwise, developed in-house by Dr T. Brown), and all data analysis was carried out essentially as described previously ([@b7]; Guilding *et al.* 2009, 2010). Bioluminescence data from the PMTs were detrended by subtracting a 24 h running average from the raw data and smoothed using a 3 h running average. Amplitude was manually measured by two experienced, independent researchers based on the peak-to-trough difference 24--48 h after culture. PMT bioluminescence recordings from +/+, *Afh*/+ and *Afh*/*Afh* groups were analysed by ANOVA with Tukey *post hoc* test using SYSTAT. Videomicroscopy bioluminescence recordings were analysed by unpaired *t* tests. The proportion of rhythmic cells between +/+ and *Afh*/*Afh* groups was tested using χ^2^ with Yate\'s correction, while cellular synchrony was assessed and visualised using Rayleigh analysis (custom software designed in-house by Dr T. Brown and El Temps). In all tests a *P-*value of \<0.05 was considered statistically significant.

Results
=======

Wheel-running activity in +/+, *Afh*/+ and *Afh*/*Afh* mice
-----------------------------------------------------------

In +/+ and *Afh*/+ mice, wheel-running behaviour was closely synchronised to a 12 h:12 h LD cycle in all individuals, with activity largely confined to the dark period and peaking ∼2 h after lights off ([Fig. 1](#fig01){ref-type="fig"}; [Table 1](#tbl1){ref-type="table"}). In contrast, entrainment of *Afh*/*Afh* mutant mice to the LD cycle was variable, with individual animals ranging from those having strong diurnal rhythms to being completely arrhythmic. In total only 8 of the 12 mutant animals showed statistically significant (*P* \< 0.001, χ^2^ periodogram) 24 h rhythms in wheel-running activity, and rhythm strength (%*V*) in these animals was significantly reduced compared with +/+ littermates. Interestingly, when we combined the data from these animals with those from later phase-shifting experiments (see below), we identified a negative correlation between %*V* in LD and period in DD~1~ (*n*= 16; *P*= 0.008) in *Afh*/*Afh* mice.

![Behavioural characterisation of wheel-running behaviour in +/+, *Afh*/+ and *Afh*/*Afh* mice\
Double-plotted actograms (*A*) and χ^2^ periodograms (*B*) showing wheel-running rhythms of individual +/+, *Afh*/+ and *Afh*/*Afh* mice under LD and DD conditions. *C*, double-plotted 24 h wheel-running activity profiles in +/+, *Afh*/+ and *Afh*/*Afh* animals, normalised to lie between 0 and 1. The mean values for each genotype have been renormalised and smoothed (3 h running average). The shaded areas in *A*--*C* indicate epochs of darkness.](tjp0591-1063-f1){#fig01}

###### 

Summary data of wheel-running analysis of +/+, *Afh*/+ and *Afh*/*Afh* mice

                                                    +/+              *Afh*/+                   *Afh*/*Afh*                    Significance
  ------------------------------------------------- ---------------- ------------------------- ------------------------------ --------------
  LD                                                                                                                          
   *N*                                              14               8                         12 (8 rhythmic)                
   Period (h)                                       23.97 ± 0.02     23.99 ± 0.02              25.30 ± 0.89                   n.s.
   Strength of rhythm (%*V*)                        48.73 ± 3.47     59.32 ± 7.38              **[32.82 ± 6.00]{.ul}**\*      *P*= 0.025
   Locomotor activity (Wheel revs h^−1^)            674.66 ± 65.92   829.95 ± 183.60           702.34 ± 115.14                n.s.
   Percentage of activity in dark phase             91.82 ± 2.02     89.94 ± 3.65              **[76.82 ± 5.64]{.ul}**\*      *P*= 0.042
   ZT of nocturnal activity peak                    13.99 ± 0.56     13.89 ± 0.52              **[17.50 ± 1.51]{.ul}**\*      *P*= 0.019
  DD1                                                                                                                         
   *N*                                              14               8                         12                             
   Period (h)                                       23.74 ± 0.06     **[24.11 ± 0.08]{.ul}**   **[26.62 ± 0.19]{.ul}**\*      *P*= 0.0001
   Strength of rhythm (%*V*)                        45.79 ± 3.08     44.31 ± 4.40              39.41 ± 2.78                   n.s.
   Locomotor activity (Wheel revs h^−1^)            714.99 ± 70.63   773.71 ± 197.38           784.59 ± 85.48                 n.s.
   Phase shift on transfer to DD (min)              43.94 ± 8.77     **[4.80 ± 17.64]{.ul}**   **[−202.95 ± 46.86]{.ul}**\*   *P*= 0.0001
   Alpha duration (h)                               12.67 ± 0.74     14.94 ± 1.08              **[15.54 ± 0.60]{.ul}**        *P*= 0.017
   Alpha duration as a percentage DD~1-10~ period   53.38 ± 3.04     61.85 ± 4.52              58.44 ± 0.60                   n.s.
   Percentage of activity in alpha in DD~1-10~      90.55 ± 1.55     95.32 ± 0.69              89.25 ± 2.19                   n.s.
  DD2                                                                                                                         
   *N*                                              14               6                         8                              
   Period DD (h)                                    23.79 ± 0.12     **[24.30 ± 0.14]{.ul}**   **[26.36 ± 0.16]{.ul}**\*      *P*= 0.0001
   Strength of rhythm in DD~10−20~ (%*V*)           38.83 ± 4.82     40.00 ± 5.94              37.33 ± 3.16                   n.s.
   Rel. change in %*V* (DD~10−20~ :DD~1-10~)        −0.16 ± 0.07     −0.13 ± 0.07              −0.07 ± 0.10                   n.s.

Wheel-running parameters of rhythmic mice measured in LD, DD~1-10~ and DD~10−20~. %*V*= percentage of variance explained by the dominant component of the rhythm; rev h^−1^= revolutions per hour; alpha = consolidated active phase. Values are expressed as mean ± SEM. Bold underlined values are statistically different from +/+ mice. \*Indicates statistically significant differences between *Afh*/+ and *Afh*/*Afh* groups (one-way ANOVA followed by Tukey *post hoc* analyses; *P* \< 0.05; significance column shows results of ANOVA). DD, constant darkness; LD, light/dark; ZT, Zeitgeber time.

The percentage of total activity observed during the dark phase was also reduced in *Afh*/*Afh* mutants, and the peak of the activity rhythm was delayed by ∼3.5 h relative to that of +/+ or *Afh*/+ littermates.

On transfer to DD, the three genotypes differed significantly in the magnitude of phase shift relative to the previous LD cycle. The phase of activity onset upon release to DD was advanced by 44 ± 9 min in +/+ mice and by 5 ± 18 min in *Afh*/+ animals Conversely, the onset of activity on the first cycle in DD was delayed by over 3 h (203 ± 47 min) in *Afh*/*Afh* mutants. During the first 10 days in DD (DD~1-10~), all +/+ mice free-ran robustly with a mean period of 23.74 ± 0.06 h and rhythm strength (%*V*) of 45.79 ± 3.08%. The mean period in heterozygote animals was slightly longer than this (24.11 ± 0.08 h), and this was further increased in *Afh*/*Afh* mutants to 26.62 ± 0.19 h (individual animals ranged from 25.58 to 27.66 h). The duration of this active phase was significantly longer in *Afh*/*Afh* mice than in +/+ littermates, in parallel with the increase in overall period (*P* \< 0.05; [Table 1](#tbl1){ref-type="table"}). In contrast with LD conditions, all *Afh*/*Afh* animals were rhythmic in DD, and %*V* in *Afh*/+ and *Afh*/*Afh* mice was only slightly reduced compared with that of congenic +/+ controls. Differences in period between +/+, *Afh*/+ and *Afh*/*Afh* animals were maintained in DD~10−20~, and rhythm strength deteriorated to a similar extent in all three genotypes ([Table 1](#tbl1){ref-type="table"}; %*V* DD~10−20~: DD~1-10~; *P* \> 0.05). These inter-genotype differences were maintained in individual +/+, *Afh*/+ and *Afh*/*Afh* mice that free-ran with a single dominant period in behaviour for up to 10 weeks in DD (data not shown).

Drinking rhythms
----------------

To determine whether behavioural lengthening in *Afh*/*Afh* mutant animals was also maintained in the absence of a running wheel, drinking rhythms were monitored continuously under LD and DD conditions. Like wheel-running activity, drinking behaviour in all three genotypes followed a characteristic diurnal pattern ([Fig. 2*A*](#fig02){ref-type="fig"}), with water intake peaking ∼2 h after dark onset. Rhythm strength was again significantly reduced in *Afh*/*Afh* mice compared with +/+ littermates (%*V Afh*/*Afh*: 23.10 ± 2.44; +/+: 45.40 ± 6.52; *P*= 0.014), although entrainment to the LD cycle varied less between individuals than in wheel-running studies and all *Afh*/*Afh* mice (*n*= 5) were rhythmic ([Fig. 2*B*](#fig02){ref-type="fig"}; [Table 2](#tbl2){ref-type="table"}).

![Drinking rhythms in +/+, *Afh*/+ and *Afh*/*Afh* mice\
Double-plotted actograms (*A*) and χ^2^ periodograms (*B*) of drinking rhythms in representative +/+, *Afh*/+ and *Afh/Afh* mice under LD and DD conditions. Shaded areas in *A* indicate epochs of darkness.](tjp0591-1063-f2){#fig02}

###### 

Summary of drinking parameters in +/+, *Afh*/+ and *Afh*/*Afh* mice

                                                   +/+            *Afh*/+        *Afh/Afh*                   Significance
  ------------------------------------------------ -------------- -------------- --------------------------- --------------
  LD                                                                                                         
   *N*                                             5              4              5                           
   Period (h)                                      24.00 ± 0.07   24.19 ± 0.02   24.75 ± 0.60                n.s.
   Strength of rhythm (%*V*)                       45.40 ± 6.52   27.66 ± 3.98   **[23.10 ± 2.44]{.ul}**     *P*= 0.014
   Total water intake (ml day^−1^)                 5.54 ± 0.49    5.54 ± 0.44    4.77 ± 0.39                 n.s.
   Percentage of drinking activity in dark phase   74.44 ± 4.97   67.81 ± 4.50   62.80 ± 4.74                n.s
  DD                                                                                                         
   *N*                                             5              5              6                           
   Period (h)                                      23.85 ± 0.04   24.25 ± 0.13   **[25.67 ± 0.21]{.ul}\***   *P*= 0.0001
   Strength of rhythm (%*V*)                       23.74 ± 4.44   18.80 ± 2.11   20.88 ± 2.25                n.s.
   Total water intake (ml day^−1^)                 5.92 ± 0.63    5.30 ± 0.69    5.35 ± 0.47                 n.s.
   Alpha duration (h)                              9.45 ± 0.59    9.30 ± 0.70    **[11.78 ± 0.61]{.ul}\***   *P*= 0.026
   Alpha duration as a percentage DD period        39.62 ± 2.54   38.40 ± 3.08   45.80 ± 2.04                n.s.
   Percentage of drinking activity in alpha        60.22 ± 2.54   54.52 ± 4.45   63.01 ± 1.98                n.s.

Parameters of drinking and water consumption of mice classified as rhythmic in LD and DD. %*V*= percentage of variance explained by the dominant component of the rhythm; alpha = main active phase. Values are expressed as mean ± SEM. Bold underlined values are statistically different from +/+ mice. \*Indicates statistically significant differences between *Afh*/+ and *Afh*/*Afh* groups (one-way ANOVA followed by Tukey *post hoc* analyses; *P* \< 0.05). *-*values refer to the first level of ANOVA. DD, constant darkness; LD, light/dark.

In DD, drinking rhythms free-ran with a circadian pattern similar to that of locomotor activity. The mean period was significantly longer in *Afh*/*Afh* mice than +/+ animals, and *Afh*/+ animals again displayed an intermediate phenotype (+/+ 23.85 ± 0.04 h; *Afh*/+ 24.25 ± 0.13 h; *Afh*/*Afh* 25.67 ± 0.21 h). As with wheel-running behaviour, alpha duration of the drinking rhythm was increased in mutant animals in proportion to the extension in circadian period, and no differences in the percentage of total drinking behaviour within alpha were identified between genotypes.

Metabolic activity rhythms
--------------------------

To further investigate the effects of the Fbxl3 mutation on feeding behaviour and metabolic rhythms, we assessed the metabolic rate of +/+ (*n*= 9) and *Afh*/*Afh* (*n*= 10) mice via indirect calorimetry. Oxygen consumption (VO~2~) in +/+ mice exhibited a clear diurnal rhythm ([Fig. 3*A* and *E*](#fig03){ref-type="fig"}), with χ^2^ periodogram analysis revealing the presence of a significant (*P* \< 0.001) ∼24 h rhythm, which peaked at ZT13.5 ([Table 3](#tbl3){ref-type="table"}). VO~2~ rhythms were mirrored by rhythms in food hopper visits ([Fig. 3*B* and *F*](#fig03){ref-type="fig"}; [Table 3](#tbl3){ref-type="table"}).

![Altered diurnal patterns of metabolic activity in *Afh*/*Afh* mutant mice\
*A*--*D*, daily patterns of O~2~ consumption (*A*, *C*) and food hopper visits (*B*, *D*) in a +/+ (+/+; *A*, *B*) and *Afh* mutant mouse (*Afh*/*Afh*; *C*, *D*) housed under a 12 h:12 h LD cycle. The bottom panels show the mean daily activity profiles for those individuals. *E*--*H*, population averaged (mean ± SEM), normalised, 24 h profiles of O~2~ consumption (*E*, *G*) and food hopper visits (*F*, *H*) in +/+ (*E*, *F*) and *Afh*/*Afh* mice (*G*, *H*). *I* and *J*, double-plotted overlay of +/+ and *Afh*/*Afh* population profiles of O~2~ consumption (*I*) and food hopper visits (*J*). Shaded areas in *A*--*J* indicate epochs of darkness.](tjp0591-1063-f3){#fig03}

###### 

Comparison of daily oxygen consumption and food hopper visits between +/+ and *Afh*/*Afh* mice

                                        +/+            *Afh*/*Afh*               Significance
  ------------------------------------- -------------- ------------------------- --------------
  *N*                                   9              10                        
  O~2~ consumption                                                               
   χ^2^ Periodogram                                                              
    % Rhythmic                          100            90                        
    Period (h)                          23.97 ± 0.04   24.11 ± 0.16              n.s.
    Rhythm strength (%*V*)              33.19 ± 3.04   32.97 ± 2.77              n.s.
   24 h average                                                                  
    ZT of peak (h)                      13.72 ± 0.57   **[16.57 ± 0.76]{.ul}**   *P*= 0.022
    Mean (ml kg^−1^ h^−1^)              3053 ± 173     2760 ± 169                n.s.
    P-T amplitude (ml kg^−1^ h^−1^)     2482 ± 254     2278 ± 290                n.s.
  Food hopper visits                                                             
   χ^2^ Periodogram                                                              
    % Rhythmic                          100            70                        
    Period (h)                          23.95 ± 0.04   24.04 ± 0.13              n.s.
    Rhythm strength (%*V*)              28.36 ± 2.78   29.04 ± 2.59              n.s.
   24 h average                                                                  
    ZT of peak (h)                      14.21 ± 0.68   **[17.02 ± 1.01]{.ul}**   *P*= 0.016
    Mean (counts per 10 min)            11.39 ± 1.69   11.7 ± 2.32               n.s.
    P-T amplitude (counts per 10 min)   43.34 ± 7.74   40.2 ± 5.6                n.s.

Data are presented as mean ± SEM. Bold, underlined values indicate statistically significant differences between +/+ and *Afh*/*Afh* mice (unpaired *t* test; *P* \< 0.05 required for significance). Only data from animals classified as rhythmic were used in the analysis of 24 h averages. ZT, Zeitgeber time.

All but one *Afh*/*Afh* mice also showed statistically significant (*P* \< 0.001, χ^2^ periodogram) 24 h rhythms in VO~2~ ([Fig. 3*C* and *G*](#fig03){ref-type="fig"}; [Table 3](#tbl3){ref-type="table"}). However, by contrast with +/+ mice, peak O~2~ consumption in these mutant animals was shifted by ∼3 h to the mid-dark phase ([Table 3](#tbl3){ref-type="table"}; *t* test *P* \< 0.05). There were no significant differences in the amplitude or overall level of day/night profiles of VO~2~ between mutant and +/+ mice. As with +/+ mice, daily profiles of food hopper activity of *Afh*/*Afh* mice largely paralleled changes in metabolic rate, with peak levels near the middle of the dark phase ([Fig. 3*D* and *G*](#fig03){ref-type="fig"}; [Table 3](#tbl3){ref-type="table"}). While we did not detect any clear difference in the amplitudes of these rhythms compared with +/+ animals, χ^2^ periodogram analysis revealed a significant rhythm (*P* \< 0.001) in only 7 out of 10 of these *Afh*/*Afh* mice.

Phase-resetting to light
------------------------

We investigated whether *Afh*/*Afh* mice are more susceptible to external resetting stimuli than +/+ mice *in vivo* by delivering a series of light pulses to mice free-running in DD and assessing resulting shifts in the phase of wheel-running activity. As expected, light pulses in the early subjective night resulted in phase-delays in wheel-running behaviour, while in the late night such pulses resulted in phase advances ([Fig. 4*A* and *B*](#fig04){ref-type="fig"}). A higher amplitude phase--response curve was seen in *Afh*/*Afh* mice than in +/+ controls. All shifts in +/+ animals were less than 5 h in magnitude, whereas ∼40% of those in *Afh*/*Afh* mutants were larger than 5 h ([Fig. 4*C* and *D*](#fig04){ref-type="fig"}; values were calculated in circadian hours to take into account the longer endogenous period of *Afh*/*Afh* animals). Interestingly, *Afh*/*Afh* mice exhibited a 'breakpoint' ([@b22]) in response to light pulses at CT17--18, after which it was difficult to distinguish phase advances from phase-delays. This resulted in a period of overlap where phase shifts in either direction were observed, and it was therefore necessary to consider delays and advances separately during statistical analysis of genotypes differences. Phase-delays in response to CT12--18 pulsing were significantly larger in *Afh*/*Afh* mice than +/+ animals (+/+: 3.27 ± 0.24 h; *Afh*/*Afh*: 5.99 ± 1.29 h; *P* \< 0.001). Similarly, phase advances in response to CT17--24 pulsing were significantly greater in *Afh*/*Afh* than +/+ mice (*Afh*/*Afh*: 4.60 ± 0.64 h; +/+: 1.15 ± 0.22 h; *P* \< 0.05). When the phase shift data were plotted as a phase--transition curve, the +/+ data had an average slope of 1, indicating Type 1 resetting ([Fig. 4*E*](#fig04){ref-type="fig"}). In contrast, we observed Type 0 resetting in *Afh*/*Afh* mice ([Fig. 4*F*](#fig04){ref-type="fig"}). Rayleigh plots depicting the phase of the onset of activity rhythms in relation to the beginning of the 6 h light pulse demonstrate that *Afh*/*Afh* mice were reset by the light pulse, so that phase is significantly correlated with the time of pulse (*P* \< 0.001, *r*= 0.527), whereas the phase in +/+ control mice was not (*P* \> 0.5, *r*= 0.149; [Fig. 4*G* and *H*](#fig04){ref-type="fig"}).

![Phase-shifting responses of circadian wheel-running rhythms to light in *Afh*/*Afh* and +/+ mice\
*A* and *B*, wheel-running activity records of representative *Afh*/*Afh* and +/+ mice given 6 h (CT) light pulses at a series (*n*= 3) of different circadian phases. *A*, data are double-plotted so that 2 days are represented on each horizontal line. To enable clear visualisation of phase-shifting effects in the *Afh*/*Afh* mouse (*B*), this plot reflects the stable free-running phase of this animal (∼26.5 h). Grey shading represents periods of darkness, and stars indicate the start of the light pulse. Phase--response curve to light pulses in +/+ (*n*= 8) (*C*) and *Afh*/*Afh* (*n*= 8) (*D*) mice. The *x*-axis is in circadian hours and the points plotted are the CT at the beginning of the light pulse. The *y*-axis is the shift in activity onset caused by the pulse. *E*, *F*, data from *C*, *D* replotted as phase--transition curves in response to light pulses in +/+ (*E*) and *Afh*/*Afh* (*F*) mice. The *x*-axis represents the CT of the light pulse and the *y*-axis represents the new phase (CT) of the slice extrapolated from the reset rhythm. *G*, *H*, Rayleigh plots depicting the phase of onset of activity rhythms (black circles) in relation to the time from the beginning of the 6 h light pulse. The direction of the arrow indicates the mean phase vector and its length shows significance relative to the significance threshold (*P*= 0.05) indicated by the inner broken circle. Boxes surrounding arrowheads show variance of phase between cultures. *Afh*/*Afh* mice are significantly reset by the light pulse, whereas +/+ mice are not (significant clustering of phases observed in *Afh*/*Afh* mice: Rayleigh test; *P* \< 0.001).](tjp0591-1063-f4){#fig04}

Molecular rhythms *in vitro*
----------------------------

To investigate whether the enhanced phase-resetting effects of light are reflected in altered amplitude and function of the molecular clock, we assessed PER2::LUC activity in the SCN, and extra-SCN oscillators of the PIT, Arc complex, DMH and Hb (Guilding *et al.* 2009, 2010; [@b19]). The *Afh* mutation significantly lengthened period in the SCN, PIT, Arc complex and DMH, in a gene dose-dependent manner ([Fig. 5](#fig05){ref-type="fig"}; [Table 4](#tbl4){ref-type="table"}). Period was also lengthened in the Hb, but this did not reach significance. A significant reduction in amplitude of PER2::LUC rhythms was observed in the SCN and PIT between +/+ and *Afh*/*Afh* mice, and between *Afh*/*Afh* and *Afh*/+ mice in the PIT ([Fig. 5](#fig05){ref-type="fig"}; [Table 4](#tbl4){ref-type="table"}). Subsequent treatment of cultures with 10 μ[m]{.smallcaps} forskolin restored high-amplitude PER2::LUC rhythms in all tissues examined (data not shown). Because all cultures were prepared from rhythmic animals free-running in DD, this demonstrates that the observed changes in the molecular rhythms were not attributable to altered entrainment to the LD cycle.

![PMT recordings of PER2::LUC expression in slice cultures from control (+/+), *Afh*/+ (+/−) and *Afh*/*Afh* (−/−) mice\
The left column shows representative detrended PER2::LUC bioluminescence rhythms from +/+ (black traces) and *Afh*/*Afh* (blue traces) in (*A*) suprachiasmatic nucleus (SCN), (*B*) pituitary (PIT), (*C*) arcuate (Arc) complex, (*D*) dorsomedial hypothalamus (DMH) and (*E*) habenula (Hb) over 7 days in culture. Inserts in *B*--*E* show expansion of the first 4 days in culture of tissues from *Afh*/*Afh* mice. Histograms in the middle and right columns show corresponding genotype measures (mean ± SEM) of the period and amplitude, respectively, of these rhythms for each tissue. Black colour boxes, +/+; light blue shaded boxes, *Afh*/+; dark blue shaded boxes, *Afh*/*Afh*. Inter-genotype differences in these measures as assessed by Tukey *post hoc* tests are indicated by the asterisks. \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001.](tjp0591-1063-f5){#fig05}

###### 

Comparison of rhythms in PER2::LUC in +/+, *Afh*/+ and *Afh*/*Afh* mice from slice cultures recorded in PMTs

                *N*   \% slices rhythmic   Period (h)                  Amplitude (cpm)
  ------------- ----- -------------------- --------------------------- -------------------------
  SCN                                                                  
   +/+          24    100                  24.04 ± 0.25                15076 ± 2512
   *Afh/*+      10    100                  24.61 ± 0.37                7847 ± 3275
   *Afh/Afh*    21    95.2                 **[25.61 ± 0.27]{.ul}**     **[7123 ± 1484]{.ul}**
  PIT                                                                  
   +/+          24    100                  23.59 ± 0.17                20924 ± 3000
   *Afh/*+      13    84.6                 24.68 ± 0.9                 5995 ± 1992
   *Afh/Afh*    15    93.3                 **[26.63 ± 0.44]{.ul}\***   **[2311 ± 417]{.ul}\***
  Arc complex                                                          
   +/+          25    88                   23.3 ± 0.35                 830 ± 230
   *Afh/*+      14    71.4                 24.3 ± 0.56                 796 ± 246
   *Afh/Afh*    21    52.4                 **[24.9 ± 0.49]{.ul}**      168 ± 37 
  DMH                                                                  
   +/+          25    84                   23.13 ± 0.56                587 ± 127
   *Afh/*+      14    78.6                 22.88 ± 0.74                629 ± 165
   *Afh/Afh*    21    52.4                 **[26.16 ± 0.91]{.ul}\***   229.9 ± 40  
  Hb                                                                   
   +/+          12    66.7                 22.11 ± 0.10                514 ± 143
   *Afh/*+      5     80                   23.91 ± 0.98                417 ± 117
   *Afh/Afh*    14    50                   24.68 ± 1.11                205 ± 103

Values are expressed as mean ± SEM. Bold underlined values are statistically different from +/+ mice. \*Indicates statistically significant differences between *Afh*/+ and *Afh*/*Afh* groups. Arc, arcuate nucleus; DMH, dorsomedial hypothalamus; Hb, habenula; PIT, pituitary; SCN, suprachiasmatic nucleus.

We have shown above that *Afh*/*Afh* mice show alterations in phase-resetting *in vivo* in response to light pulses, and that the molecular oscillators in the SCN and PIT are significantly reduced in amplitude. We therefore hypothesised that the SCN and PIT oscillators are more susceptible to phase-resetting when cultured, a phenomena we have previously demonstrated in lower amplitude circadian oscillators ([@b15]; [@b19]). By preparing cultures at a range of times across the circadian cycle from animals free-running in DD conditions, we assessed whether the phase of PER2:LUC rhythms in culture reflected the *in vivo* CT phase or was reset by the culture procedure (i.e. peaked a set time after tissue collection). Rayleigh analysis of phase clustering between different slices showed that +/+ and *Afh*/+ SCN peak phase was significantly associated with CT ([Fig. 6](#fig06){ref-type="fig"}; +/+: *P* \< 0.00001; *Afh*/+: *P* \< 0.02) and not with time of cull (all *P* \> 0.05); rhythms peaked at a mean phase of CT13.01 ± 0.7 and CT13.98 ± 1.36 respectively. Intriguingly, *Afh*/*Afh* SCN were reset by the culture procedure with PER2::LUC rhythms peaking consistently ∼32 h after cull (32.34 ± 1.4 h), regardless of the circadian phase of tissue preparation ([Fig. 6](#fig06){ref-type="fig"}). Similarly, +/+ and *Afh*/+ PIT phase was also significantly associated with CT phase ([Fig. 6](#fig06){ref-type="fig"}; +/+: *P* \< 0.00001, CT 17.8 ± 1.2; *Afh*/+: *P* \< 0.02, CT 23.67 ± 1.0) and not with time from cull (all *P* \> 0.05), while the peak phase in mutants was consistently reset to ∼29 h after cull (*P* \< 0.03, 28.6 ± 1.3 h).

![Cultured suprachiasmatic nucleus (SCN) and pituitary (PIT) from +/+ mice maintain a phase consistently correlated with the animals circadian time (CT) *in vivo*, while *Afh*/*Afh* SCN and PIT are reset by the culture procedure\
Rayleigh plots show peak PER2::LUC phase for +/+ and *Afh*/*Afh* SCN and PIT recorded in PMTs, plotted as either CT (based on behavioural rhythms in DD) or time of peak bioluminescence after culture preparation (time from culture). Circles (open: +/+; filled: *Afh*/*Afh*) indicate the phase of peak bioluminescence in individual cultures. Both SCN and PIT from +/+ mice express peak PER2::LUC bioluminescence at a consistent circadian phase, regardless of cull/culture time (peak phase is correlated with CT not with time from culture). However, *Afh*/*Afh* SCN and PIT always peak the same number of hours after culture preparation, showing these tissues to be reset by this process (peak phase correlated with time from culture not CT).](tjp0591-1063-f6){#fig06}

In contrast, the phase of peak PER2::LUC expression in the Arc complex and DMH from +/+ mice did not correlate with CT and instead were significantly associated with time from cull/culture preparation (Arc complex: *P* \< 0.00001, peak 34.9 ± 0.74 h following cull; DMH: *P* \< 0.02, peak 32.6 ± 1.3 h following cull). The phase of peak PER2::LUC expression in both tissues from Afh/+ and *Afh*/*Afh* mice did not correlate with either CT or time from cull (all *P* \> 0.05). In addition, the peak phase in the Hb was not correlated with CT or time from culture in any genotype (all *P* \> 0.05).

Bioluminescence imaging of molecular rhythms in the MBH and SCN
---------------------------------------------------------------

Arc complex cultures contain within them the Arc, ME, PT and the ependymal cell layer of the third ventricle (Epe), while DMH cultures contain DMH and the adjacent Epe. To further assess and differentiate the effects of the *Afh* mutation on these tissues, and on single cells within these tissues, we imaged coronal slices of the MBH using a highly sensitive EM-CCD luminescence imaging camera. In both +/+ and *Afh*/*Afh* mice we observed circadian rhythms in PER2::LUC expression in the Arc, DMH, ME/PT and the Epe. The *Afh* mutation significantly lengthened the period of PER2::LUC rhythms in all MBH regions examined ([Fig. 7](#fig07){ref-type="fig"}; [Table 5](#tbl5){ref-type="table"}). A proportionally greater increase in period length in *Afh*/*Afh vs*. +/+ mice was observed in the Arc and DMH than in the ME and Epe ([Table 5](#tbl5){ref-type="table"}), suggesting that different MBH regions are differentially sensitive to the *Afh* mutation. While the amplitude of rhythms showed a trend towards a decrease in all tissues from *Afh*/*Afh* mice, this only reached significance in the Arc ([Fig. 7](#fig07){ref-type="fig"}; [Table 5](#tbl5){ref-type="table"}). However, the rate of damping of rhythms was significantly faster in all MBH regions from *Afh*/*Afh* mice ([Table 5](#tbl5){ref-type="table"}).

![Comparison of PER2::LUC rhythms in the MBH of +/+ and *Afh*/*Afh* mice\
*A*, EM-CCD image illustrating PER2::LUC bioluminescence in the dorsomedial hypothalamus (DMH), arcuate nucleus (Arc), median eminence (ME) and the ependymal cell layer of the 3rd ventricle (Epe), but not in the ventromedial hypothalamus (VMH). Calibration bar: 250 μm. *B*, histograms summarising period and amplitude differences of PER2::LUC rhythms for different tissues between +/+ and *Afh*/*Afh* mice. The *Afh* mutation results in a significant lengthening of period in all tissues, and a decrease in amplitude in the Arc; \**P* \< 0.05 *vs.*+/+ in each tissue. The DMH and Arc have significantly shorter periods in +/+ mice than ME and Epe; †*P* \< 0.05 (one-way ANOVA with Tukey *post hoc* tests); however, this difference is not present in *Afh*/*Afh* mice. *C*, plots of detrended PER2::LUC expression integrated across delineated Arc, DMH, Epe and ME from a representative +/+ and *Afh*/*Afh* MBH slice culture. The bottom two panels show representative single cells in the Arc and DMH.](tjp0591-1063-f7){#fig07}

###### 

Summary of circadian rhythms of PER2::LUC expression in hypothalamic tissues recorded using a bioluminescence imaging camera

               *N*   \% slices rhythmic   Period (h)       \% increase in period *vs*. +/+   Amplitude     Rate of damping (days)
  ------------ ----- -------------------- ---------------- --------------------------------- ------------- ------------------------
  Arc                                                                                                      
   +/+         10    100                  21.4 ± 0.7       12.5                              1413 ± 192    5.8 ± 0.56
   *Afh/Afh*   11    82                   24.0 ± 0.5\*\*                                     410 ± 186\*   2.5 ± 0.56\*\*\*
  DMH                                                                                                      
   +/+         10    100                  21.2 ± 0.4       13.4                              772 ± 185     5.7 ± 0.47
   *Afh/Afh*   11    63.6                 24.0 ± 1.0\*                                       416 ± 167     2.5 ± 0.70\*\*
  ME                                                                                                       
   +/+         10    100                  23.8 ± 0.4       9.1                               2470 ± 1420   7.0 ± 0.43
   *Afh/Afh*   10    70                   26.0 ± 0.8\*                                       1061 ± 654    4.2 ± 0.8\*\*
  Epe                                                                                                      
   +/+         10    100                  23.5 ± 0.6       10.3                              2090 ± 1364   6.6 ± 0.76
   *Afh/Afh*   10    80                   26.0 ± 0.8\*                                       354 ± 117     3.3 ± 0.67\*\*
  SCN                                                                                                      
   +/+         5     100                  23.7 ± 0.3       9.0                               5447 ± 155    n/a
   *Afh/Afh*   5     100                  25.8 ± 1.4\*                                       3307 ± 964    n/a

Values are expressed as mean ± SEM. \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001 unpaired *t* test. Arc, arcuate nucleus; DMH, dorsomedial hypothalamus; Epe, ependymal cell layer of the 3rd ventricle; ME, median eminence; SCN, suprachiasmatic nucleus.

We assessed whether peak phase of PER2::LUC expression in the MBH of +/+ and *Afh*/*Afh* mice was associated with a particular CT phase or was reset by the culture procedure. Overall, both +/+ Arc and DMH peak phase was significantly associated with time of cull (both *P* \< 0.00001, Rayleigh analysis; [Fig. 8](#fig08){ref-type="fig"}) and not CT; rhythms consistently peaked at ∼28 h after cull (Arc: 27.7 ± 0.5 h; DMH: 27.9 ± 0.7 h). *Afh*/*Afh* Arc and DMH peak phase did not significantly correlate with time of cull or CT ([Fig. 8](#fig08){ref-type="fig"}). Conversely, +/+ ME peak phase was significantly correlated with CT (CT peak 19.6 ± 1.2 h; *P* \< 0.01; [Fig. 8](#fig08){ref-type="fig"}) and not with time from cull, while the phase of *Afh*/*Afh* ME was not consistently associated with either a particular circadian phase or time following cull. Peak phase in the Epe in both +/+ and *Afh*/*Afh* varied widely between individuals and was not consistently associated with either a particular circadian phase or duration of time following cull (Rayleigh associations with CT and cull all *P* \> 0.05).

![The phases of MBH tissues *in vitro* are differentially affected by the culture procedure and by the *Afh*/*Afh* mutation\
Rayleigh plots show peak PER2::LUC phase for +/+ and *Afh*/*Afh* MBH regions imaged on an EM-CCD camera, plotted as either circadian time (CT; based on behavioural rhythms in DD) or time of peak bioluminescence after culture preparation (time from culture). Circles (open: +/+; filled: *Afh*/*Afh*) indicate the phase of peak bioluminescence in MBH regions delineated from individual cultures. Arcuate nucleus (Arc) and dorsomedial hypothalamus (DMH) from +/+ mice are reset by the culture procedure, while the median eminence (ME)/pars tuberalis (PT) maintains a phase consistently correlated with CT. All regions from *Afh*/*Afh* mice are not correlated with either CT or time from culture. Ep, ependymal cell layer of the 3rd ventricle.](tjp0591-1063-f8){#fig08}

To determine whether the *Afh* mutation also influenced cellular oscillations of PER2::LUC in the MBH, single cells were discriminated in the Arc and DMH of +/+ and *Afh*/*Afh* mice ([Fig. 7](#fig07){ref-type="fig"}). In total 205 cells were visualised in the Arc from +/+ mice, 91.2% of which were rhythmic; and 125 cells were visualised in the Arc from mutant animals, 60% of which were rhythmic. In the DMH 142 cells were discriminated in slices from +/+ mice, 85.9% of which were rhythmic; and 125 cells were visualised in the DMH from mutant mice, 53.6% of which were rhythmic. There was a significant decrease in the proportion of rhythmic cells in *Afh*/*Afh vs*. +/+ slices in Arc and DMH (*P* \< 0.0001, *X*-squared with Yate\'s correction).

The period of rhythms in single cells lengthened significantly in *Afh*/*Afh vs.*+/+ mice in both the Arc (+/+: 22.7 ± 0.19 h; *Afh*/*Afh*: 23.4 ± 0.29 h; *P* \< 0.02, unpaired *t* test) and the DMH (+/+: 21.8 ± 0.2 h; *Afh*/*Afh*: 22.9 ± 0.2 h; *P* \< 0.002). '*R*'-values from Rayleigh tests on the second day in culture indicated that there was no significant reduction in synchrony between single cells in *Afh*/*Afh* mice with respect to +/+, in either the Arc or DMH (Arc: +/+, *r* = 0.57 ± 0.04, *Afh*/*Afh*, *r*= 0.71 ± 0.06; DMH: +/+, *r*= 0.62 ± 0.09, *Afh*/*Afh*, *r*= 0.47 ± 0.18; all *P* \> 0.05). While oscillating cells were detected in +/+ mice for up to the end of the recording cycle (at least 7 days), we could not assess synchrony of *Afh*/*Afh* cells at a later time point as we have done previously ([@b15]), because after the third day in culture there were not consistently enough single cells oscillating to allow Rayleigh plots to be performed. This presumably stems from the significantly reduced amplitude of single-cell oscillations observed in *Afh*/*Afh* mice in both the Arc (+/+: 5231 ± 410; *Afh*/*Afh*: 1964 ± 260; *P* \< 0.0001) and the DMH (+/+: 2963 ± 592; *Afh*/*Afh*: 1317 ± 184; *P* \< 0.0001, unpaired *t* test).

Consistent with imaging experiments in the MBH, period was significantly lengthened in the SCN of *Afh*/*Afh vs.*+/+ mice, and there was a trend towards a reduction in amplitude ([Table 5](#tbl5){ref-type="table"}). All 150 cells identified in the SCN of +/+ mice were rhythmic, and 98% of the 148 cells discriminated in the SCN of *Afh*/*Afh* mutants were rhythmic. The period of single-cell oscillations in the SCN lengthened significantly from 23.64 ± 0.23 h in +/+ mice to 25.77 ± 0.05 h in *Afh*/*Afh* animals (*P* \< 0.0001).

The *Afh* mutation significantly reduced the amplitude of single-cell rhythms in the SCN (+/+: 5304 ± 262; *Afh*/*Afh*: 3767 ± 224; *P* \< 0.0001; [Fig. 9](#fig09){ref-type="fig"}). We therefore assessed whether this was accompanied by a loss of synchrony between individual SCN cells. Rayleigh analysis revealed that cells were significantly synchronised on the second day in all +/+ and *Afh*/*Afh* SCN cultures. *R*-values did not differ significantly between genotypes after 2 days in culture (+/+, *r*= 0.93 ± 0.03; *Afh*/*Afh*, *r*= 0.94 ± 0.03; *P* \> 0.05, unpaired *t* test; [Fig. 9](#fig09){ref-type="fig"}), indicating no reduction in cell synchrony due to the *Afh* mutation. Most cells in both +/+ and *Afh*/*Afh* SCN slices had not significantly damped by the end of the recording period, so for this tissue it was possible to also determine cellular synchrony at a later time point. Cell synchrony after 5 days in culture tended to be lower in *Afh*/*Afh* (*r*= 0.66 ± 0.08) than in +/+ (*r*= 0.83 ± 0.06; [Fig. 9](#fig09){ref-type="fig"}) SCNs and, while differences only approached significance (*P*= 0.052), this trend suggests that after a longer time in culture, faster desynchronisation between cells in the SCN of *Afh*/*Afh* mice may lead to an increased rate of damping relative to +/+ SCNs.

![Cell synchrony in +/+ and *Afh/Afh* SCN slices\
*A*, plots of integrated bioluminescence for representative individual cells in the SCN of +/+ (upper trace) and *Afh*/*Afh* (lower trace) mice. The inserts show expansion of single-cell traces for days 5--9 in culture. The amplitude of single-cell oscillations was lower in *Afh/Afh* compared with +/+ SCN slices, and cells tended to become desynchronised over time in culture. *B*, Rayleigh vector plots showing phase clustering of cells in the SCN of +/+ and *Afh*/*Afh* mice. Circles (open: +/+; filled: *Afh*/*Afh*) indicate the phase of peak PER2::LUC bioluminescence in individual cells visualised from the same slice at 2 days and 5 days following culture. Phases are plotted relative to time of culture. Single-cell rhythms in both +/+ and *Afh*/*Afh* SCN were tightly synchronised on day 2 in culture. Lower *R*-values on day 5 *in vitro* indicate a progressive reduction in cell synchrony. No significant differences between genotypes were observed in phase clustering (*P* \> 0.05), although cells tended to be less well synchronised in *Afh*/*Afh* than +/+ cultures after 5 days in culture.](tjp0591-1063-f9){#fig09}

Discussion
==========

Here we show that the *Afh* mutation elicits alterations in metabolic and ingestive rhythms. These may in part be controlled by the changes we demonstrate in molecular oscillators in metabolically important brain regions. We provide the first examination of phase-shifting behaviour in these mice and uncover rare Type 0 resetting, which is associated with enhanced phase-resetting of molecular clocks *in vitro*. Our current findings add to our understanding of circadian phase-resetting, and indicate that the amplitude of individual cellular oscillators is a key component in maintenance of phase.

The significant reduction in the strength of diurnal wheel-running and drinking rhythms in homozygous *Afh* mutants is indicative of impaired photic entrainment. We observed variation in the precision of entrainment of *Afh*/*Afh* animals to LD using all of the methods described in this study, and mutant individuals were identified that were arrhythmic for either locomotor or metabolic activity. In a previous study, all *Afh*/*Afh* mice entrained to the LD cycle ([@b29]), although the authors here did not comment on whether diurnal rhythm strength was affected by genotype. [@b13] did, however, report variable behaviour of *Afh*/*Afh* mice on return to LD following 19 days in DD, with some mice failing to re-entrain. It is also noteworthy that in the *Afh*/*Afh* mice that were significantly rhythmic under LD in our study, diurnal rhythm strength was negatively correlated with period length in DD. Therefore, whether or not diurnal entrainment is achieved appears to depend on the amount by which an individual\'s natural activity onset deviates from the exogenous LD cycle. Once released into DD, both +/+ and *Afh*/*Afh* mice were able to maintain robust rhythms for up to 10 weeks, and there was no evidence that free-running rhythm strength deteriorated more quickly in *Afh/Afh* mice. The alteration in endogenous period by the *Afh* mutation does not therefore significantly impair the strength of the endogenous rhythm once external phase-shifting influences are removed.

Interestingly, *tau* homozygote mutant mice, which express a 20 h circadian period of wheel-running in DD, also display a range of phenotypes in diurnal conditions, again with some individuals failing to entrain to the LD cycle ([@b30]; [@b29]). Stabilisation of clock gene proteins is also disrupted in these animals, but in this case results in enhanced degradation of PER with consequent shortening of the free-running period and advanced onset of wheel-running activity in LD. In the case of *Afh/Afh* mutants, we identified a significant delay relative to +/+ controls in the timing of peak wheel-running activity under diurnal conditions. Such delays correlate with the altered phasing of clock gene and protein expression associated with the *Afh* and *overtime* mutations, determined previously using *in situ* hybridisation, real-time polymerase chain reaction and Western blotting ([@b13]; [@b36]). It is important to note, however, that, unlike wheel-running rhythms, the reduced amplitude of clock gene oscillations in *Afh* mice persists in DD.

Metabolic and feeding rhythms were also delayed 3--4 h in *Afh*/*Afh* mice under LD, mirroring alterations in the molecular clockwork and wheel-running activity. While overall amplitudes of VO~2~ and food hopper activity rhythms were not significantly reduced under LD, we did observe *Afh*/*Afh* mice that lacked a significant diurnal rhythm in one or other parameter (see [Table 3](#tbl3){ref-type="table"}). Alterations in drinking rhythms in *Afh*/*Afh* mice were closely correlated to wheel-running rhythms, showing decreased diurnal strength and increased circadian period. There are numerous reciprocal connections between the SCN and the hypocretin and other energy balance systems, and mutations affecting the circadian system can alter metabolism and ingestive behaviours ([@b35]; [@b38]; [@b7]). For example, *Clock* mutant mice have severely attenuated feeding rhythms under diurnal conditions ([@b38]), and similar reductions in the amplitudes of plasma glucose and triglyceride rhythms are reported in mice lacking *Bmal1* ([@b35]).

Phase-shifting behaviour has not previously been determined for *Afh* mice. Our *in vivo* resetting study revealed a high-amplitude Type 0-like phase-resetting in *Afh*/*Afh* mice in response to light. This is of importance because nocturnal rodents typically display Type 1 phase-resetting *in vivo*; indeed Type 0 resetting has only been reported in mice lacking core molecular clock components ([@b39]; [@b24]; [@b9]). The circadian pacemaker has been modelled across a diverse range of species as a van der Pol limit cycle oscillator ([@b21]; [@b28]; [@b14]; [@b20]; [@b41]; [@b27]). Thus, the ability of perturbing stimuli to phase shift an oscillator is inversely correlated with the internal amplitude of the oscillation ([@b3]; [@b32]; [@b23]). Consequently, Type 0 resetting results from a high-intensity phase-shifting stimuli or a decrease in the amplitude of the oscillator. Takahashi and colleagues provided evidence that the decrease in amplitude of the molecular oscillator in *Clock* heterozygous mutant mice resulted in high-amplitude Type 0 phase-resetting ([@b39]). Further, high-amplitude phase-resetting was observed in the *Rev-Erba*/*Per1* double mutant mouse, which displayed damped oscillations of several clock genes (but not *Per2*) in the SCN ([@b24]).

In our study, we observe a decrease in the amplitude of the molecular clock not just in the SCN pacemaker, but also in extra-SCN oscillators. This decrease can result from either a decrease in the amplitude (or proportion) of individual oscillating cells, or from a reduction in synchrony among the population, damping the combined output of the oscillator. To determine the mechanism underlying the reduction in oscillator amplitude from tissues in the brain of *Afh*/*Afh* mice, we imaged cells in the SCN, Arc and DMH, and assessed their individual amplitudes. One can predict from the limit cycle model that because we observed much larger phase-shifting responses to light in the *Afh*/*Afh vs.*+/+ mice, oscillating single cells would be of lower amplitude but still synchronised, which is indeed what we observed. However, while it was not possible to assess cellular synchrony in the MBH beyond a few days in culture, there was some indication that within the SCN, individual cells may become desynchronised more quickly over time as a result of the *Afh* mutation. Desynchronisation of SCN cellular oscillators is strongly associated with aberrant rhythms in SCN clock gene expression and behaviour ([@b18]; [@b4]), and exercise in a running wheel can stabilise behavioural rhythms in such animals ([@b33]). Because *Afh/Afh* mice maintain stable wheel-running and drinking rhythms in DD conditions, this suggests that feedback from general locomotor activity and/or wheel-running stabilises the SCN of the animals such that the individual SCN cells do not desynchronise.

The mechanism underlying enhanced *in vivo* behavioural resetting likely involves enhanced resetting of the molecular clockwork. When cultured *in vitro*, +/+ SCN and PIT exhibit peaks in PER2::LUC at a consistent CT, which corresponds to their previously published circadian phases *in vivo* and *in vitro* ([@b2]; [@b5]; [@b15]; [@b19]). Hence, these +/+ oscillators resist the phase-resetting stimuli of the cull/culturing process. We hypothesised that weakening of the molecular clock in *Afh*/*Afh* mice may render the previously robust oscillators in the SCN and PIT unable to resist phase shifts. Indeed, we found that these tissues taken from *Afh*/*Afh* mice do not peak at a consistent time relative to their previous *in vivo* phase. Instead, they are reset so they consistently peak the same time after cull regardless of the circadian phase of cull. These data indicate that the ability of a given tissue to maintain its *in vivo* phase when cultured depends on the strength of the oscillator ([@b15]; [@b12]; [@b19]). Accordingly, +/+ ME, the strongest (highest amplitude, least damping) of all the oscillators in the MBH maintains a phase correlated to circadian time when cultured, whereas the less robust MBH oscillators in the Arc and DMH, and the oscillator in the Hb are easily reset by the phase-shifting effects of the culturing process. This enhanced phase-resetting in response to culture is similar to that recently observed in the SCN of VPAC~2~RKO mice, which also display low-amplitude molecular rhythms ([@b19]).

Circadian clocks throughout the body display different characteristics, as exemplified by significant differences in intrinsic circadian period between hypothalamic oscillators ([@b15]) and by the substitution of CLOCK with NPAS2 in the forebrain ([@b34]; [@b11]). Fbxl3 is ubiquitously expressed ([@b13]; [@b10]), and its role in the regulation of circadian clockwork appears to be conserved at least throughout the brain as we see a similar tendency towards increased period length and reduced amplitude in all tissues we investigated. More recently, a homologue of Fbxl3, Fbxl21, was identified as a new clock component ([@b10]). Unlike Fbxl3, the expression of Fbxl21 is highly tissue specific, and exhibits a clock-dependent rhythm. Whether Fbxl21 differentially influences the resistance of local oscillators to phase-resetting is intriguing and remains to be explored.

In summary, we demonstrate a broad conservation of the period-lengthening and amplitude-reducing effects of the Fbxl3 mutation across the brain and peripheral regions investigated. Our results indicate that not only does the *Afh* mutation enhance *in vitro* phase-resetting of molecular rhythms, but that this is associated with high-amplitude, Type 0-like phase--response curve to light *in vivo*. Because *Afh/Afh* mutant mice maintain behavioural rhythms in constant conditions, the increased efficacy of resetting stimuli in *Afh*/*Afh* mutants is likely to be a consequence of reduced oscillator amplitude, resulting from suppressed amplitude in single cells rather than from a desynchronisation of these cells.
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*Afh*

:   after-hours

Arc

:   arcuate nucleus

BMAL1

:   Brain and Muscle ARNT-Like 1

CRY

:   Cryptochrome

CT

:   circadian time

DD

:   constant darkness

DMH

:   dorsomedial hypothalamus

Epe

:   ependymal layer

Hb

:   habenula

LD

:   light/dark

MBH

:   mediobasal hypothalamus

ME

:   median eminence

PER2::LUC

:   PERIOD2::LUCIFERASE

PIT

:   pituitary

PMT

:   photomultiplier tube

PT

:   pars tuberalis

SCN

:   suprachiasmatic nuclei

ZT

:   Zeitgeber time
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